{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:15:43Z","timestamp":1768968943549,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajog.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:36:38Z","timestamp":1686400598000},"page":"280.e1-280.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-2230","authenticated-orcid":false,"given":"Pegah","family":"Blustein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Uppalapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung Ming","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg A.","family":"Husk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill S.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine A.","family":"Villella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.06.011_bib1","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/AOG.0000000000002296","article-title":"Practice Bulletin No 182: hereditary breast and ovarian cancer syndrome","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.06.011_bib2","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.06.011_bib3","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 3.2023. NCCN clinical practice guidelines in oncology","author":"Daly","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2023.06.011_bib4","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2023.06.011_bib5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.2016.69.9330","article-title":"Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study","volume":"35","author":"Rosenthal","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib6","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.06.011_bib7","series-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the U.S. Preventive Services Task Force recommendation","author":"Nelson","year":"2013"},{"key":"10.1016\/j.ajog.2023.06.011_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ygyno.2013.06.029","article-title":"Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis","volume":"130","author":"Reade","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13697137.2018.1433656","article-title":"The role of transvaginal ultrasound in screening for ovarian cancer","volume":"21","author":"Campbell","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.ajog.2023.06.011_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.17772\/gp\/1735","article-title":"[Screening for ovarian cancer in BRCA1\/BRCA2 mutations carriers]","volume":"85","author":"Synowiec","year":"2014","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ajog.2023.06.011_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2016-0444","article-title":"Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act","volume":"22","author":"Tschernichovsky","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ajog.2023.06.011_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.06.011_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.06.011_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006250-200801000-00039","article-title":"ACOG. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.06.011_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","article-title":"Society of gynecologic oncologists clinical practice committee statement on prophylactic salpingo-oophorectomy","volume":"98","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ygyno.2012.03.009","article-title":"Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility","volume":"125","author":"Landon","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4132\/jptm.2016.06.17","article-title":"Comparison of the classical method and SEE-FIM protocol in detecting microscopic lesions in Fallopian tubes with gynecological lesions","volume":"52","author":"Koc","year":"2018","journal-title":"J\u00a0Pathol Transl Med"},{"key":"10.1016\/j.ajog.2023.06.011_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jog.13845","article-title":"Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?","volume":"45","author":"Laokulrath","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2023.06.011_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2023.06.011_bib20","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12957-017-1282-5","article-title":"\u201cBest practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty\u201d","volume":"15","author":"Malacarne","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib22","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2020.02.006","article-title":"Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: a large prospective single institution experience","volume":"157","author":"Rush","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.06.011_bib24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.06.011_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk\u00a0time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.06.011_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-2020-001541","article-title":"Preventing Ovarian Cancer through early excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial","volume":"31","author":"Gaba","year":"2021","journal-title":"Int J Gynecol Cancer"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:40:59Z","timestamp":1757590859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0002937823003800"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.06.011","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}